| 2007 | Glia-dependent TGF-β signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis | 김대기 | Article |
| 2004 | HDAC inhibitor stimulate CYP3A4 proximal activity in Hepa I and HepG2 cells | 신윤용; 김대기 | Meeting Abstract |
| 2004 | Histone deacetylase inhibitor stimulate CYP3A4 proximal promoter activity in HepG2 cells | 신윤용; 김대기 | Article |
| 2008 | Identification of human cytochrome P450 enzymes involved in the metabolism of IN-1130, a novel activin receptor-like kinase-5 (ALK5) inhibitor | 신윤용; 김대기 | Article |
| 2009 | IN-1130, a novel transforming growth factor-β type I receptor kinase (Activin Receptor-like Kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's disease | 김대기 | Article |
| 2006 | IN-1130, a novel transforming growth factor-β type I receptor kinase (ALK5) inhibitor, suppresses renal fibrosis in obstructive nephropathy | 신윤용; 김대기 | Article |
| 2010 | IN-1233, an ALK-5 inhibitor: Prevention of granulation tissue formation after bare metallic stent placement in a rat urethral model | 김대기 | Article |
| 2013 | IN-1233-eluting covered metallic stent to prevent hyperplasia: Experimental study in a rabbit esophageal model | 김대기 | Article |
| 2011 | Increased transforming growth factor beta 1 expression mediates ozone-induced airway fibrosis in mice | 김대기 | Article |
| 2006 | MMTV/c-Neu transgenic mice as a model to study antitumor activity against breast cancer in vivo | 신윤용; 김대기 | Meeting Abstract |
| 2010 | Novel ALK5 Inhibitor Inhibits Breast Tumor Metastasis and Increases the Interactions of SnoN and Ski to the Promoters of TGF beta Target Genes. | 신윤용; 김대기 | Meeting Abstract |
| 2016 | Novel oral transforming growth factor- signaling inhibitor EW-7197 eradicates CML-initiating cells | 신윤용; 김대기 | Article |
| 2009 | Ozone Induces Pulmonary Fibrosis via a TGF-beta Signaling Pathway | 김대기 | Meeting Abstract |
| 2008 | Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4- (quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide; a novel ALK5 inhibitor and a potential anti-fibrosis drug | 신윤용; 이화정; 김대기 | Article |
| 2015 | Phosphorylation status determines the opposing functions of Smad2/Smad3 as STAT3 cofactors in T(H)17 differentiation | 김대기 | Article |
| 2006 | Potent in vivo anti-breast cancer activity of IN-2001, a novel inhibitor of histone deacetylase, in MMTV/c-Neu Mice | 신윤용; 김대기 | Article |
| 2011 | Role of IN-1233 in the prevention of neointimal hyperplasia after stent placement in a rat artery model | 김대기 | Article |
| 2004 | Site-specific Tc-99m-labeling of antibody using dihydrazinophthalazine (DHZ) conjugation to Fc region of heavy chain | 김대기 | Article |
| 2011 | Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin- 2-yl)-4-(quinolin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기 | Article |
| 2011 | Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin- 2-yl)-4-(quinoxalin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기 | Article |
| 2011 | Synthesis and biological evaluation of 1-substituted-3-(6-methylpyridin-2- yl)-4-([1,2,4triazolo[1,5-apyridin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기 | Article |
| 2012 | Synthesis and biological evaluation of 2-benzylamino-4(5)-(6-methylpyridin- 2-yl)-5(4)-([1,2,4]triazolo[1,5-a]-pyridin-6-yl)thiazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기; 김승원 | Article |
| 2010 | Synthesis and biological evaluation of 2-pyridyl-substituted pyrazoles and imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 김대기 | Article |
| 2003 | Synthesis and Biological Evaluation of 3-(4-Substituted-phenyl)-N-hydroxy-2-propenamides, a New Class of Histone Deacetylase Inhibitors | 김대기 | Article |
| 2007 | Synthesis and biological evaluation of 4(5)-(6-alkylpyridin-2-yl)imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 김대기 | Article |
| 2010 | Synthesis and biological evaluation of 4(5)-(6-methylpyridin-2-yl)imidazoles and -pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기 | Article |
| 2015 | Synthesis and biological evaluation of 5-(fluoro-substituted-6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-alpha]pyridin-6-yl)imidazoles as inhibitors of transforming growth factor-beta type I receptor kinase | 신윤용; 김대기 | Article |
| 2008 | Synthesis and biological evaluation of 5-(pyridin-2-yl)thiazoles as transforming growth factor-β type1 receptor kinase inhibitors | 김대기 | Article |
| 2009 | Synthesis and biological evaluation of benzenesulfonamide-substituted 4-(6-alkylpyridin-2-yl)-5-(quinoxalin-6-yl)imidazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 김대기 | Article |
| 2004 | Synthesis and biological evaluation of novel 2-pyridinyl-[1,2,3]triazoles as inhibitors of transforming growth factor β1 type 1 receptor | 김대기 | Article |
